CVS 📈 CVS Health - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1266501006

CVS: Health Insurance, Pharmacy Services, Prescription Drugs, Wellness Products

CVS Health Corporation is a leading healthcare company in the United States, offering a range of health solutions to individuals, employers, and healthcare providers. The company operates through three main segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.

The Health Care Benefits segment provides a variety of health insurance products and services to a diverse range of customers, including employer groups, individuals, college students, and government-sponsored plans. This segment offers traditional, voluntary, and consumer-directed health insurance products, catering to the unique needs of its customers.

The Health Services segment focuses on pharmacy benefit management solutions, designed to help employers, insurance companies, and healthcare providers manage their pharmacy benefits effectively. This segment offers a range of services, including plan design and administration, formulary management, and clinical services, to name a few. By providing these services, CVS Health helps its customers reduce healthcare costs and improve health outcomes.

The Pharmacy & Consumer Wellness segment is responsible for selling prescription and over-the-counter drugs, as well as consumer health and beauty products, through its retail stores, online platforms, and mail-order services. This segment also provides pharmacy consulting and ancillary services to care facilities, such as long-term care pharmacies, on-site pharmacies, and retail specialty pharmacy stores. Additionally, CVS Health offers compounding pharmacies and branches for infusion and enteral nutrition services, further expanding its reach in the healthcare industry.

With a rich history dating back to 1996, CVS Health Corporation has undergone significant transformations, including a name change from CVS Caremark Corporation to CVS Health Corporation in 2014. Today, the company is headquartered in Woonsocket, Rhode Island, and is a leading player in the healthcare industry, committed to providing innovative health solutions to its customers.

For more information about CVS Health Corporation, please visit their website at https://www.cvshealth.com.

Additional Sources for CVS Stock

CVS Stock Overview

Market Cap in USD 75,454m
Sector Healthcare
Industry Healthcare Plans
GiC Industry Health Care Providers & Services
TER 0.00%
IPO / Inception 1984-12-17

CVS Stock Ratings

Growth 5y -13.4%
Fundamental -7.36%
Dividend 66.1%
Rel. Performance Sector -2.27
Analysts 4/5
Fair Price Momentum 56.39 USD
Fair Price DCF 34.68 USD

CVS Dividends

Dividend Yield 12m 4.49%
Yield on Cost 5y 4.11%
Annual Growth 5y 3.89%
Payout Consistency 96.43%

CVS Growth Ratios

Growth Correlation 3m -18.3%
Growth Correlation 12m -69.4%
Growth Correlation 5y 15%
CAGR 5y -1.78%
CAGR/Mean DD 5y -0.10
Sharpe Ratio 12m -0.36
Alpha -39.78
Beta 0.75
Volatility 27.93%
Current Volume 9011.5k
Average Volume 20d 12682.4k
What is the price of CVS stocks?
As of December 04, 2024, the stock is trading at USD 59.19 with a total of 9,011,484 shares traded.
Over the past week, the price has changed by +0.31%, over one month by +8.31%, over three months by +4.30% and over the past year by -9.95%.
Is CVS Health a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, CVS Health is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -7.36 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CVS as of December 2024 is 56.39. This means that CVS is currently overvalued and has a potential downside of -4.73%.
Is CVS a buy, sell or hold?
CVS Health has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy CVS.
  • Strong Buy: 11
  • Buy: 6
  • Hold: 11
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CVS stock price target?
According to ValueRays Forecast Model, CVS CVS Health will be worth about 60.9 in December 2025. The stock is currently trading at 59.19. This means that the stock has a potential upside of +2.91%.
Issuer Forecast Upside
Wallstreet Target Price 68.4 15.5%
Analysts Target Price 90.2 52.3%
ValueRay Target Price 60.9 2.9%